On the other hand, the OCSC marker c-KIT is highly expressed in hypoxic tumor microenvironments, which leads to β-catenin activation and high expression of ABC transporters that cause resistance to cisplatin/paclitaxel [46]. This evidence concerns the gene KIT and neoplasm.